Fludarabine, Cyclophosphamide and Rituximab (FCR) As First Line Treatment in Patients with Chronic Lymphocytic Leukemia (CLL): A Long-Term Analysis of the German CLL Study Group (GCLLSG) RegistryNadine Kutsch,Anna Maria Fink, Anno Federhen,Adam Giza,Sandra Robrecht, Janina Stumpf,Andrea Stoltefuß,Ursula Vehling-Kaiser,Michael Koenigsmann,Eugen Tausch,Christof Schneider,Stephan Stilgenbauer,Thomas Illmer,Rudolf Schlag,Steffen Dörfel,Tobias Gaska,Michael G. Kiehl,Kirsten Fischer,Barbara Eichhorst,Michael HallekBlood(2022)引用 0|浏览20暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要